Overview

FocalTherics France, legally known as EDAP TMS S.A., is a medical technology company founded in 1979 and headquartered in Vaulx-en-Velin, France. It is privately held, with an estimated 200-500 employees and estimated revenue of $50-100 million. The company makes robotic focal therapy and non-invasive therapeutic ultrasound systems for medical use. Its flagship Focal One robotic HIFU platform is used by urologists for focal ablation of prostate tissue. The company serves hospitals and clinics, and it is recently expanding its applications to endometriosis treatment in Europe.

At a glance

What FocalTherics France makes

Its products include the Focal One robotic HIFU platform, along with associated disposables, leasing options, treatment services, and maintenance, and it holds ISO 13485 certification.

Certifications

FocalTherics France is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

• ISO 13485 — linkedin.com

Latest developments

• 2026-11-05 — FocalTherics™ Reports Third Quarter 2026 Financial Results | Focal One® (focalone.com)

• 2026-10-29 — Toutes nos félicitations à la Clinique Urologique Nantes Atlantis pour cette étape remarquable: 1 000 traitements par HIFU réalisés pour le cancer de la prostate! | FocalTherics France (linkedin.com)

• 2026-10-20 — Toutes nos félicitations aux équipes de la Clinique du Cèdre pour le déploiement de la technologie HIFU robotisée Focal One® dans leur établissement! | FocalTherics France (linkedin.com)

• 2026-08-11 — FocalTherics™ Announces Proposed Public Offering of American Depositary Shares | Focal One® (focalone.com)

• 2026-06-30 — FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients | Focal One® (focalone.com)

• 2026-06-30 — FocalTherics lance le premier programme commercial Focal One pour l'endométriose en Europe avec le traitement des premières patientes | Zonebourse (zonebourse.com)

Company details

The company operates in the automotive, electric-vehicle, medical, and industrial-equipment sectors according to the record, with its medical systems used by academic, public, and private hospitals and clinics. FocalTherics France was founded in 1979, has an estimated 200-500 employees, and is headquartered in Vaulx-en-Velin, Auvergne-Rhone-Alpes. On the LightSource stability read it is rated "Established & active": 47 years in operation (founded 1979). Holds ISO 13485 certification(s) per public sources.

Frequently asked questions

What does FocalTherics France make?

FocalTherics France, legally known as EDAP TMS S.A., is a medical technology company founded in 1979 and headquartered in Vaulx-en-Velin, France. It is privately held, with an estimated 200-500 employees and estimated revenue of $50-100 million. The company makes robotic focal therapy and non-invasive therapeutic ultrasound systems for medical use. Its flagship Focal One robotic HIFU platform is used by urologists for focal ablation of prostate tissue. The company serves hospitals and clinics, and it is recently expanding its applications to endometriosis treatment in Europe.

Where is FocalTherics France headquartered?

FocalTherics France is headquartered in Vaulx-en-Velin, Auvergne-Rhone-Alpes (4 Rue du Dauphine, Vaulx-en-Velin, Auvergne-Rhone-Alpes, 69120).

When was FocalTherics France founded?

FocalTherics France was founded in 1979.

How big is FocalTherics France?

FocalTherics France has an estimated 200-500 employees, with revenue in the $50-100M range (estimated).

What certifications does FocalTherics France hold?

FocalTherics France lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.

Related suppliers

Explore other suppliers in the LightSource directory:

• 10xEngineers

• 1X

• 365 Retail Markets

• 3Com

• 3PAR

Last verified Nov 2026. Is this your company? Request a correction.